A 304-pt trial will measure the efficacy of PICO in the prevention of SSI from cardiac surgery under extracorporeal circulation vs Aquacel Surgical. The primary outcome is incidence of infection of the sternal wound. Est study completion is Jul 13, 2021. clinicaltrials.gov
A Cochrane review assessed the effects of ES on treating PUs. The review concluded that ES probably increases the proportion of PUs healed and the rate of healing but there is uncertainty related to time to complete healing and whether ES decreases wound surface area. Cochrane
A 52-pt RCT evaluated autologous skin cell suspension (ASCS)+compression vs compression alone for the treatment of VLUs. At wk 14, VLUs treated w/ ASCS + compression had a statistically greater decrease in ulcer area vs control (8.94 cm2 versus 1.23 cm2, P = .0143). IWJ
Aposcience AG will initiate a 132-pt Phase I and Phase II clinical study in Austria to evaluate the efficacy and safety of APO-2 in tx of DFUs w/ the primary outcome for Phase 2 being % wound area reduction at 4 wks. The study is to be completed Nov 2021. clinicaltrials.gov
A 167-pt study compared the efficacy of the combination of NPWT w/ monolateral pectoralis muscle flap vs bilateral flap reconstruction in reducing sternal wound infection following sternotomy. The study found mono‐pectoralis group resulted in fewer complications. IWJ
A 98-pt clinical study in underway in Nigeria to evaluate outcomes of post-operative hip and proximal thigh wounds dressed with Post-Op Opsite vs povidone-iodine based dressing. No trial completion date was provided. Contemp Clin Trials CommS
The top 15 global Advanced Wound companies depend on SmartTRAK to provide up-to-date intel on industry trends, news, financial data and competitor developments. All subscribers receive a Daily Updates email containing the latest need-to-know news from earnings calls, conferences, studies, patent filings, new products and more, all curated by our analysts. It's the perfect way to start your day! If you would like a demo of all SmartTRAK has to offer, just click the button below.
